Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Journal of Korean Medical Science|December 29, 2007
Meta-analysis of the association between HLA-DRB1 allele and rheumatoid arthritis susceptibility in Asian populationsKyung Ran Jun, Sung Eun Choi, Choong Hwan Cha, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 9, 2008
Compound heterozygous mutations in severe factor VII deficiency including a novel nonsense mutationSun-Min Lee, Yong-Seok Heo, Eun-Yup Lee, et al.
Journal of Hepatology|November 21, 2007
Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70-74 of the HLA-DRB1 moleculeYoung-Suk Lim, Heung-Bum Oh, Sung-Eun Choi, et al.
Biochemical Pharmacology|November 26, 2008
MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetinJong-Eun Kim, Jung Yeon Kwon, Dong Eun Lee, et al.
Oncotarget|February 25, 2016
Bakuchiol suppresses proliferation of skin cancer cells by directly targeting Hck, Blk, and p38 MAP kinaseJong-Eun Kim, Jae Hwan Kim, Younghyun Lee, et al.
The Journal of Biological Chemistry|August 29, 2007
Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathwayNam Joo Kang, Ki Won Lee, Evgeny A Rogozin, et al.
BMB Reports|November 8, 2013
Binding model for eriodictyol to Jun-N terminal kinase and its anti-inflammatory signaling pathwayEunjung Lee, Ki-Woong Jeong, Areum Shin, et al.
International Journal of Molecular Sciences|June 26, 2025
Structural Insights into the ADCC Mechanism and Resistance of Mogamulizumab, a First-in-Class Anti-CCR4 Therapy for Cutaneous T Cell LymphomaSeung Beom Choi, Hyun Tae Lee, Nahyeon Gu, et al.
Acta Crystallographica. Section F, Structural Biology Communications|September 9, 2014
Crystallization and preliminary X-ray crystallographic analysis of the PH-GRAM domain of human MTMR4Jee Un Lee, Ji Young Son, Ki-Young Yoo, et al.
Biomedicines|December 23, 2022
The High-Resolution Structure Reveals Remarkable Similarity in PD-1 Binding of Cemiplimab and Dostarlimab, the FDA-Approved Antibodies for Cancer ImmunotherapyTae-Jun Jeong, Hyun-Tae Lee, Nahyeon Gu, et al.
Pageof 10